SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001415889-15-002464
Filing Date
2015-07-27
Accepted
2015-07-27 17:06:27
Documents
3
Period of Report
2015-08-26
Effectiveness Date
2015-07-27

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT mbvxdef14a_aug2015.htm DEF 14A 977666
2 mabvax1.jpg GRAPHIC 627357
3 mabvax2.jpg GRAPHIC 388115
  Complete submission text file 0001415889-15-002464.txt   2378156
Mailing Address 11588 SORRENTO VALLEY ROAD SUITE 20 SAN DIEGO CA 92121
Business Address 11588 SORRENTO VALLEY ROAD SUITE 20 SAN DIEGO CA 92121 8582599405
MABVAX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001109196 (see all company filings)

IRS No.: 930987903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-31265 | Film No.: 151007679
SIC: 2834 Pharmaceutical Preparations